News
Results from the first part of a Phase I/II trial (NCT06569823) showed that Z-1018 generated immune responses comparable to ...
Bavarian Nordic AS (BVNKF) reports a 33% revenue increase and secures significant public preparedness contracts, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback